Hiromi Kanai

Fujita Health University

Papers

1

Total Citations

9

H-Index

1

About

Dr. Hiromi Kanai is a pioneering figure in the field of robotic colorectal surgery, with a focused expertise in advancing minimally invasive techniques for rectal cancer treatment. Her most notable contribution is a landmark 2025 study that conducted the first propensity score–matched comparison of the novel hinotori Surgical Robot System against the industry-standard da Vinci platform for rectal cancer surgery. This work, which has already garnered 9 citations in its first year, critically evaluated short-term surgical outcomes, providing essential evidence for the adoption of next-generation robotic systems. By demonstrating the safety and efficacy of hinotori, Dr. Kanai’s research directly impacts surgical decision-making and patient care, positioning her at the forefront of surgical innovation. Her comparative analysis not only validates new technology but also sets a rigorous methodological standard for future robotic surgery trials. Dr. Kanai’s work is instrumental for surgeons and researchers seeking to optimize robotic platforms, making her a key voice in the evolution of precision surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Propensity score–matched comparison of robot-assisted rectal cancer surgery using hinotori and da Vinci
9 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Fujita Health University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago